General Information of the Protein
Protein ID
PT01063
Protein Name
Serine/threonine-protein kinase Sgk1
Secondarily
Protein Name
Serum/glucocorticoid-regulated kinase 1
Gene Name
SGK1
Secondarily
Gene Name
SGK
Sequence
MTVKTEAAKGTLTYSRMRGMVAILIAFMKQRRMGLNDFIQKIANNSYACKHPEVQSILKISQPQEPELMNANPSPPPSPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGKSPDSVLVTASVKEAAEAFLGFSYAPPTDSFL
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
AGC protein kinase group
>
AGC protein kinase SGK family
Function
Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cellular enzymes, transcription factors, neuronal excitability, cell growth, proliferation, survival, migration and apoptosis. Plays an important role in cellular stress response. Contributes to regulation of renal Na(+) retention, renal K(+) elimination, salt appetite, gastric acid secretion, intestinal Na(+)/H(+) exchange and nutrient transport, insulin-dependent salt sensitivity of blood pressure, salt sensitivity of peripheral glucose uptake, cardiac repolarization and memory consolidation. Up-regulates Na(+) channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2, K(+) channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2 and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2, SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT, SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes: GSK3A/B, PMM2 and Na(+)/K(+) ATPase, and transcription factors: CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport into epithelial cells by enhancing the stability and expression of SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L ubiquitin E3 ligase, promoting its interaction with 14-3-3 proteins, thereby preventing it from binding to SCNN1A/ENAC and targeting it for degradation. Regulates store-operated Ca(+2) entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1 directly via its phosphorylation or indirectly via increased interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and activates MDM2-dependent ubiquitination of p53/TP53. Phosphorylates MAPT/TAU and mediates microtubule depolymerization and neurite formation in hippocampal neurons. Phosphorylates SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates APBB1/FE65 and promotes its localization to the nucleus. Phosphorylates MAPK1/ERK2 and activates it by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7 and plays an inhibitory role in the NOTCH1 signaling. Phosphorylates FOXO1 resulting in its relocalization from the nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit from the nucleus and interference with FOXO3-dependent transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits their activity. Phosphorylates SLC9A3/NHE3 in response to dexamethasone, resulting in its activation and increased localization at the cell membrane. Phosphorylates CREB1. Necessary for vascular remodeling during angiogenesis. Sustained high levels and activity may contribute to conditions such as hypertension and diabetic nephropathy. Isoform 2 exhibited a greater effect on cell plasma membrane expression of SCNN1A/ENAC and Na(+) transport than isoform 1.
    Show/Hide
Uniprot ID
Primary ID:
O00141

Secondarily ID:
B7UUP7
B7UUP8
B7UUP9
B7Z5B2
E1P583
Q5TCN2
Q5TCN3
Q5TCN4
Q5VY65
Q9UN56
    Show/Hide
Ensembl ID
ENSG00000118515
HGNC ID
HGNC:10810
Subcellular Location
Cytoplasm
Nucleus
Endoplasmic reticulum membrane
Cell membrane
Mitochondrion
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000013 , Sf9
Compound ID Compound Name Compound Formula
CP0382724
3-(2,2-difluoro-10,12-dimethyl-1-aza-3-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-3,5,7,9,11-pentaen-4-yl)-N-[2-[2-[2-[2-[[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]amino]ethoxy]ethoxy]ethoxy]ethyl]propanamide
   Show/Hide
C49H54BF2N7O7
 1
1
Kd = 331 nM
   TI
   LI
   LO
   TS
CP0382649
3-(2,2-difluoro-10,12-dimethyl-1-aza-3-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-3,5,7,9,11-pentaen-4-yl)-N-[2-[2-[2-[2-[[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-methylamino]ethoxy]ethoxy]ethoxy]ethyl]propanamide
   Show/Hide
C50H56BF2N7O7
 1
1
Kd = 566 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0174809
N-[4-(3-amino-2H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]-5-chloro-2-fluorobenzenesulfonamide
   Show/Hide
C17H12ClFN6O2S
 2
1 IC50 = 1 nM
2 IC50 = 41 nM
CP0174801
2,5-dichloro-N-[4-(3-methyl-2H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl]benzenesulfonamide
   Show/Hide
C18H13Cl2N5O2S
 1
1 IC50 < 1.2 nM
CP0362282
N-[4-[4-(3-aminopropoxy)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-2,5-dichlorobenzenesulfonamide
   Show/Hide
C20H18Cl2N6O3S
 1
1 IC50 < 1.2 nM
CP0529536
5-chloro-2-fluoro-N-[4-[4-(4-hydroxycyclohexyl)oxy-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]benzenesulfonamide
   Show/Hide
C23H21ClFN5O4S
 1
1 IC50 < 1.2 nM
CP0251208
2-fluoro-N-[4-(4-methoxy-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl]-5-methylbenzenesulfonamide
   Show/Hide
C19H16FN5O3S
 1
1 IC50 = 1.5 nM
CP0508305
5-chloro-2-cyano-N-[4-[4-(4-hydroxycyclohexyl)oxy-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]benzenesulfonamide
   Show/Hide
C24H21ClN6O4S
 1
1 IC50 < 1.5 nM
CP0557683
N-[4-(3-amino-4-cyclopropyl-2H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl]-2-cyano-5-methoxybenzenesulfonamide
   Show/Hide
C22H19N7O3S
 1
1 IC50 < 1.5 nM
CP0701895
5-chloro-2-fluoro-N-(4-(4-((1r,4r)-4-hydroxycyclohexyloxy)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)benzenesulfonamide
   Show/Hide
C23H21ClFN5O4S
 1
1 IC50 < 1.5 nM
CP0881986
2-fluoro-N-(4-(4-((1r,4r)-4-hydroxycyclohexyloxy)-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-5-methoxybenzenesulfonamide
   Show/Hide
C25H26FN5O5S
 1
1 IC50 < 1.5 nM
CP0122711
2-chloro-5-methoxy-N-[4-(3-methyl-2H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]benzenesulfonamide
   Show/Hide
C19H16ClN5O3S
 2
1 IC50 = 2 nM
2 IC50 = 34 nM
CP0174805
2-fluoro-5-methyl-N-[4-(3-methyl-2H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]benzenesulfonamide
   Show/Hide
C19H16FN5O2S
 2
1 IC50 = 2 nM
2 IC50 = 29 nM
CP0226675
N-[4-(3-amino-2H-pyrazolo[3,4-b]pyrazin-6-yl)-2-fluorophenyl]-2,5-dichlorobenzenesulfonamide
   Show/Hide
C17H11Cl2FN6O2S
 2
1 IC50 = 2 nM
2 IC50 = 13 nM
CP0259103
N-[4-(3-amino-2H-pyrazolo[3,4-b]pyrazin-6-yl)-2-fluorophenyl]-5-chloro-2-fluorobenzenesulfonamide
   Show/Hide
C17H11ClF2N6O2S
 2
1 IC50 = 2 nM
2 IC50 = 50 nM
CP0114354
N-[4-(3-amino-2H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]-2,3-dichlorobenzenesulfonamide
   Show/Hide
C17H12Cl2N6O2S
 2
1 IC50 = 3 nM
2 IC50 = 442 nM
CP0251261
2-cyano-5-methyl-N-[4-(3-methyl-2H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]benzenesulfonamide
   Show/Hide
C20H16N6O2S
 2
1 IC50 = 3 nM
2 IC50 = 580 nM
CP0142181
5-chloro-2-fluoro-N-[4-(3-methyl-2H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]benzenesulfonamide
   Show/Hide
C18H13ClFN5O2S
 2
1 IC50 = 4 nM
2 IC50 = 88 nM
CP0142180
N-[4-(3-amino-2H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]-2,5-dichlorobenzenesulfonamide
   Show/Hide
C17H12Cl2N6O2S
 2
1 IC50 = 5 nM
2 IC50 = 25 nM
CP0957712
2-fluoro-5-methyl-N-(4-(4-(morpholin-2-ylmethoxy)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)benzenesulfonamide
   Show/Hide
C23H23FN6O4S
 1
1 IC50 = 6.2 nM
CP0139935
N-[4-(4-cyclopropyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl]-2-fluoro-5-methylbenzenesulfonamide
   Show/Hide
C21H18FN5O2S
 1
1 IC50 = 6.5 nM
CP0143912
N-[4-(3-amino-2H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl]-5-chloro-2-fluorobenzenesulfonamide
   Show/Hide
C17H12ClFN6O2S
 1
1 IC50 = 19 nM
CP0556344
N-[4-[3-amino-4-(2-methylpropoxy)-2H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-2,5-dichlorobenzenesulfonamide
   Show/Hide
C21H20Cl2N6O3S
 1
1 IC50 = 130 nM
Clinical Information about the Protein
Target 1 ( Serine/threonine-protein kinase Sgk1 (SGK1) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Prostate cancer [ICD-11: 2C82.0]
Investigative Drug(s) 1 Investigative Drug  1
1 GSK-650394 Investigative
Prostate cancer